Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Finished Goods (2019 - 2025)

Pulmonx has reported Finished Goods over the past 7 years, most recently at $14.0 million for Q4 2025.

  • Quarterly Finished Goods fell 4.65% to $14.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.0 million through Dec 2025, down 4.65% year-over-year, with the annual reading at $14.0 million for FY2025, 4.65% down from the prior year.
  • Finished Goods was $14.0 million for Q4 2025 at Pulmonx, up from $13.9 million in the prior quarter.
  • Over five years, Finished Goods peaked at $16.4 million in Q1 2023 and troughed at $8.6 million in Q1 2021.
  • The 5-year median for Finished Goods is $14.7 million (2022), against an average of $14.2 million.
  • Year-over-year, Finished Goods surged 90.18% in 2021 and then decreased 14.49% in 2025.
  • A 5-year view of Finished Goods shows it stood at $12.0 million in 2021, then soared by 30.03% to $15.6 million in 2022, then rose by 2.12% to $16.0 million in 2023, then fell by 7.76% to $14.7 million in 2024, then decreased by 4.65% to $14.0 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Finished Goods are $14.0 million (Q4 2025), $13.9 million (Q3 2025), and $13.6 million (Q2 2025).